<DOC>
	<DOC>NCT00809042</DOC>
	<brief_summary>The purpose of this study is determination of the efficacy of combination of hydroxyurea with L-carnitine or magnesium in improving hematologic parameters and cardiac status in patients with β-thalassemia intermedia in comparison with hydroxyurea alone .</brief_summary>
	<brief_title>Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia</brief_title>
	<detailed_description />
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Beta thalassemia intermedia patients with mean hemoglobin level &gt;= 7gr/dl, need to blood transfusion with more than 6 months interval or no need to blood transfusion Hypothyroidism Hypoparathyroidism Diabetes mellitus Hepatitis B and C Positive tests for human immunodeficiency virus Any cardiac symptoms or receiving drug for cardiac disease Presence of other hemoglobinopathies except thalassemia intermedia and pregnant or lactating womens</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Hydroxyurea</keyword>
	<keyword>magnesium chloride</keyword>
	<keyword>L-carnitine</keyword>
	<keyword>β-thalassemia intermedia</keyword>
</DOC>